Anti-parasitic drugs mainly include: anti-malaria drugs, anti-amebiasis drugs and anti-trichomoniasis drugs, anti-leishmaniasis drugs, anti-fluke drugs and anti-filariasis drugs, intestinal anthelmintics, other parasitic drugs and other drugs.
Market Analysis and Insights: Global Ectoparasiticides Market
The global Ectoparasiticides market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Ectoparasiticides market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Ectoparasiticides, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Ectoparasiticides, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ectoparasiticides revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Ectoparasiticides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Ectoparasiticides revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis
Sanofi
Virbac
Vetoquinol
Dechra Pharmaceuticals
Advance Properties OOD/Huvepharma
Heranba
Tagros
Meghmani
Crop Life Science Limited
Aestar
Gharda
Guangdong Liwei
Segment by Type
Permethrin
Sulfur
Lindane
Benzyl Benzoate
Ivermectin
Others
Segment by Application
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Ectoparasiticides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ectoparasiticides companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ectoparasiticides revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ectoparasiticides Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Permethrin
1.2.3 Sulfur
1.2.4 Lindane
1.2.5 Benzyl Benzoate
1.2.6 Ivermectin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Ectoparasiticides Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Cattle
1.3.5 Pigs
1.3.6 Sheep and Goats
1.3.7 Poultry
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ectoparasiticides Market Perspective (2019-2030)
2.2 Global Ectoparasiticides Growth Trends by Region
2.2.1 Ectoparasiticides Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ectoparasiticides Historic Market Size by Region (2019-2024)
2.2.3 Ectoparasiticides Forecasted Market Size by Region (2025-2030)
2.3 Ectoparasiticides Market Dynamics
2.3.1 Ectoparasiticides Industry Trends
2.3.2 Ectoparasiticides Market Drivers
2.3.3 Ectoparasiticides Market Challenges
2.3.4 Ectoparasiticides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Ectoparasiticides by Players
3.1.1 Global Ectoparasiticides Revenue by Players (2019-2024)
3.1.2 Global Ectoparasiticides Revenue Market Share by Players (2019-2024)
3.2 Global Ectoparasiticides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Ectoparasiticides, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Ectoparasiticides Market Concentration Ratio
3.4.1 Global Ectoparasiticides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ectoparasiticides Revenue in 2023
3.5 Global Key Players of Ectoparasiticides Head office and Area Served
3.6 Global Key Players of Ectoparasiticides, Product and Application
3.7 Global Key Players of Ectoparasiticides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ectoparasiticides Breakdown Data by Type
4.1 Global Ectoparasiticides Historic Market Size by Type (2019-2024)
4.2 Global Ectoparasiticides Forecasted Market Size by Type (2025-2030)
5 Ectoparasiticides Breakdown Data by Application
5.1 Global Ectoparasiticides Historic Market Size by Application (2019-2024)
5.2 Global Ectoparasiticides Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ectoparasiticides Market Size (2019-2030)
6.2 North America Ectoparasiticides Market Size by Type
6.2.1 North America Ectoparasiticides Market Size by Type (2019-2024)
6.2.2 North America Ectoparasiticides Market Size by Type (2025-2030)
6.2.3 North America Ectoparasiticides Market Share by Type (2019-2030)
6.3 North America Ectoparasiticides Market Size by Application
6.3.1 North America Ectoparasiticides Market Size by Application (2019-2024)
6.3.2 North America Ectoparasiticides Market Size by Application (2025-2030)
6.3.3 North America Ectoparasiticides Market Share by Application (2019-2030)
6.4 North America Ectoparasiticides Market Size by Country
6.4.1 North America Ectoparasiticides Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Ectoparasiticides Market Size by Country (2019-2024)
6.4.3 North America Ectoparasiticides Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Ectoparasiticides Market Size (2019-2030)
7.2 Europe Ectoparasiticides Market Size by Type
7.2.1 Europe Ectoparasiticides Market Size by Type (2019-2024)
7.2.2 Europe Ectoparasiticides Market Size by Type (2025-2030)
7.2.3 Europe Ectoparasiticides Market Share by Type (2019-2030)
7.3 Europe Ectoparasiticides Market Size by Application
7.3.1 Europe Ectoparasiticides Market Size by Application (2019-2024)
7.3.2 Europe Ectoparasiticides Market Size by Application (2025-2030)
7.3.3 Europe Ectoparasiticides Market Share by Application (2019-2030)
7.4 Europe Ectoparasiticides Market Size by Country
7.4.1 Europe Ectoparasiticides Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Ectoparasiticides Market Size by Country (2019-2024)
7.4.3 Europe Ectoparasiticides Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Ectoparasiticides Market Size (2019-2030)
8.2 China Ectoparasiticides Market Size by Type
8.2.1 China Ectoparasiticides Market Size by Type (2019-2024)
8.2.2 China Ectoparasiticides Market Size by Type (2025-2030)
8.2.3 China Ectoparasiticides Market Share by Type (2019-2030)
8.3 China Ectoparasiticides Market Size by Application
8.3.1 China Ectoparasiticides Market Size by Application (2019-2024)
8.3.2 China Ectoparasiticides Market Size by Application (2025-2030)
8.3.3 China Ectoparasiticides Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Ectoparasiticides Market Size (2019-2030)
9.2 Asia Ectoparasiticides Market Size by Type
9.2.1 Asia Ectoparasiticides Market Size by Type (2019-2024)
9.2.2 Asia Ectoparasiticides Market Size by Type (2025-2030)
9.2.3 Asia Ectoparasiticides Market Share by Type (2019-2030)
9.3 Asia Ectoparasiticides Market Size by Application
9.3.1 Asia Ectoparasiticides Market Size by Application (2019-2024)
9.3.2 Asia Ectoparasiticides Market Size by Application (2025-2030)
9.3.3 Asia Ectoparasiticides Market Share by Application (2019-2030)
9.4 Asia Ectoparasiticides Market Size by Region
9.4.1 Asia Ectoparasiticides Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Ectoparasiticides Market Size by Region (2019-2024)
9.4.3 Asia Ectoparasiticides Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Ectoparasiticides Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Type
10.2.1 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Ectoparasiticides Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Application
10.3.1 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Ectoparasiticides Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Country
10.4.1 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Ectoparasiticides Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Ectoparasiticides Introduction
11.1.4 Bayer Revenue in Ectoparasiticides Business (2019-2024)
11.1.5 Bayer Recent Developments
11.2 MSD Animal Health
11.2.1 MSD Animal Health Company Details
11.2.2 MSD Animal Health Business Overview
11.2.3 MSD Animal Health Ectoparasiticides Introduction
11.2.4 MSD Animal Health Revenue in Ectoparasiticides Business (2019-2024)
11.2.5 MSD Animal Health Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Ectoparasiticides Introduction
11.3.4 Boehringer Ingelheim Revenue in Ectoparasiticides Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva Sante Animale
11.4.1 Ceva Sante Animale Company Details
11.4.2 Ceva Sante Animale Business Overview
11.4.3 Ceva Sante Animale Ectoparasiticides Introduction
11.4.4 Ceva Sante Animale Revenue in Ectoparasiticides Business (2019-2024)
11.4.5 Ceva Sante Animale Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Ectoparasiticides Introduction
11.5.4 Eli Lilly and Company Revenue in Ectoparasiticides Business (2019-2024)
11.5.5 Eli Lilly and Company Recent Developments
11.6 Zoetis
11.6.1 Zoetis Company Details
11.6.2 Zoetis Business Overview
11.6.3 Zoetis Ectoparasiticides Introduction
11.6.4 Zoetis Revenue in Ectoparasiticides Business (2019-2024)
11.6.5 Zoetis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Ectoparasiticides Introduction
11.7.4 Sanofi Revenue in Ectoparasiticides Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 Virbac
11.8.1 Virbac Company Details
11.8.2 Virbac Business Overview
11.8.3 Virbac Ectoparasiticides Introduction
11.8.4 Virbac Revenue in Ectoparasiticides Business (2019-2024)
11.8.5 Virbac Recent Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Ectoparasiticides Introduction
11.9.4 Vetoquinol Revenue in Ectoparasiticides Business (2019-2024)
11.9.5 Vetoquinol Recent Developments
11.10 Dechra Pharmaceuticals
11.10.1 Dechra Pharmaceuticals Company Details
11.10.2 Dechra Pharmaceuticals Business Overview
11.10.3 Dechra Pharmaceuticals Ectoparasiticides Introduction
11.10.4 Dechra Pharmaceuticals Revenue in Ectoparasiticides Business (2019-2024)
11.10.5 Dechra Pharmaceuticals Recent Developments
11.11 Advance Properties OOD/Huvepharma
11.11.1 Advance Properties OOD/Huvepharma Company Details
11.11.2 Advance Properties OOD/Huvepharma Business Overview
11.11.3 Advance Properties OOD/Huvepharma Ectoparasiticides Introduction
11.11.4 Advance Properties OOD/Huvepharma Revenue in Ectoparasiticides Business (2019-2024)
11.11.5 Advance Properties OOD/Huvepharma Recent Developments
11.12 Heranba
11.12.1 Heranba Company Details
11.12.2 Heranba Business Overview
11.12.3 Heranba Ectoparasiticides Introduction
11.12.4 Heranba Revenue in Ectoparasiticides Business (2019-2024)
11.12.5 Heranba Recent Developments
11.13 Tagros
11.13.1 Tagros Company Details
11.13.2 Tagros Business Overview
11.13.3 Tagros Ectoparasiticides Introduction
11.13.4 Tagros Revenue in Ectoparasiticides Business (2019-2024)
11.13.5 Tagros Recent Developments
11.14 Meghmani
11.14.1 Meghmani Company Details
11.14.2 Meghmani Business Overview
11.14.3 Meghmani Ectoparasiticides Introduction
11.14.4 Meghmani Revenue in Ectoparasiticides Business (2019-2024)
11.14.5 Meghmani Recent Developments
11.15 Crop Life Science Limited
11.15.1 Crop Life Science Limited Company Details
11.15.2 Crop Life Science Limited Business Overview
11.15.3 Crop Life Science Limited Ectoparasiticides Introduction
11.15.4 Crop Life Science Limited Revenue in Ectoparasiticides Business (2019-2024)
11.15.5 Crop Life Science Limited Recent Developments
11.16 Aestar
11.16.1 Aestar Company Details
11.16.2 Aestar Business Overview
11.16.3 Aestar Ectoparasiticides Introduction
11.16.4 Aestar Revenue in Ectoparasiticides Business (2019-2024)
11.16.5 Aestar Recent Developments
11.17 Gharda
11.17.1 Gharda Company Details
11.17.2 Gharda Business Overview
11.17.3 Gharda Ectoparasiticides Introduction
11.17.4 Gharda Revenue in Ectoparasiticides Business (2019-2024)
11.17.5 Gharda Recent Developments
11.18 Guangdong Liwei
11.18.1 Guangdong Liwei Company Details
11.18.2 Guangdong Liwei Business Overview
11.18.3 Guangdong Liwei Ectoparasiticides Introduction
11.18.4 Guangdong Liwei Revenue in Ectoparasiticides Business (2019-2024)
11.18.5 Guangdong Liwei Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis
Sanofi
Virbac
Vetoquinol
Dechra Pharmaceuticals
Advance Properties OOD/Huvepharma
Heranba
Tagros
Meghmani
Crop Life Science Limited
Aestar
Gharda
Guangdong Liwei
听
听
*If Applicable.
